Form 8-K - Current report:
SEC Accession No. 0001520138-24-000439
Filing Date
2024-11-29
Accepted
2024-11-29 15:23:10
Documents
14
Period of Report
2024-11-28
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT esg-20241128_8k.htm   iXBRL 8-K 24280
2 EXHIBIT 16.1 esg-20241128_8kex16z1.htm EX-16.1 3611
  Complete submission text file 0001520138-24-000439.txt   197132

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE esgh-20241128.xsd EX-101.SCH 3009
4 XBRL LABEL FILE esgh-20241128_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE esgh-20241128_pre.xml EX-101.PRE 24161
16 EXTRACTED XBRL INSTANCE DOCUMENT esg-20241128_8k_htm.xml XML 3222
Mailing Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348
Business Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348 267-467-5871
ESG Inc. (Filer) CIK: 0001883835 (see all company filings)

EIN.: 871918342 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56532 | Film No.: 241516258
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)